CClinicalTrials.gg
CompletedNCT05092321Updated Dec 13, 2024

Aquatic Therapy for ASD

An interventional study of Aquatic Occupational Therapy in Autism Spectrum Disorder, sponsored by Ohio State University. Completed at 1 site in United States. Open to participants aged 3 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-13.

Sponsored by Ohio State University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
3 Years to 12 Years
Sex
All
01

Study summary

This is an aquatic occupational therapy group for children between the ages of 3-12 that have an autism diagnosis. Intervention will focus on increasing the child's safety swim skills.

Read the detailed description

Information will be collected from participants' guardians during an intake visit regarding a child's sensory processing deficits, movement abilities and exposure to swim skill instruction prior to the group. The group will provide swim instruction using the Halliwick approach to learning swim skills as well as other occupational therapy techniques such as shaping, therapeutic relationship and behavior management. Groups will have a minimum ratio of 1 staff to every 2 children, with the possibility of 1:1 ratio most days. There will be a certified lifeguard present at all times. Qualitative interviews and a follow up survey will be conducted with parents (ages 18+) to determine impact on families and individual participants. Swim skills will be tracked at each session via goal attainment scaling and daily documentation. Descriptive and correlational statistics will be completed as well as coding of interview and survey data. Participants can participate for one, 10 week session, or will have the option to participate in additional 10 week sessions until child participants top out on the WOTA or plateau in progress of swim skills.

02

Conditions studied

  • Autism Spectrum Disorder
03

In context

Autism Spectrum Disorder

1,727 studies on the registry are indexed under Autism Spectrum Disorder; 504 are open to participants now.

This study's enrollment of 60 is above the median of 52 across 1,371 interventional studies indexed under Autism Spectrum Disorder.

Browse Autism Spectrum Disorder studies →

Lead sponsor

Ohio State University is the lead sponsor of 640 studies on the registry; 144 are open to participants now.

Of its 60 completed or terminated interventional studies of FDA-regulated products, 45 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • pre-existing diagnosis of autism spectrum disorder from a medical professional
  • family interest in swimming

Exclusion criteria

Exclusion Criteria:

  • ventilation system for breathing such as trachea not capped
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Aquatic Occupational Therapy

    Group-based aquatic occupational therapy with 1:1 swim buddy for safety.

    Behavioral: Aquatic Occupational Therapy

Interventions

  • BehavioralAquatic Occupational Therapy

    Group of 4-8 children, paired with a swim buddy. Intervention techniques including discrete teaching, motor shaping, behavioral management, therapeutic relationship and individualized goals.

06

What researchers measure

Primary outcomes

  1. Change in swim skills

    Change in swim skills measured with Water Orientation Test-Alyn; higher scores mean a better outcome. Minimum score is 0, maximum is 27

    Time frame: baseline, pre-intervention; immediately after the intervention

  2. Change in individualized goals

    Goal Attainment Scaling to track change in other swim performance skills not measured above. Scores for each goal range from -2 (regression) to +2 (2 levels more than anticipated). A higher score indicates improvement.

    Time frame: immediately after the intervention

  3. Change in parent comfort

    Custom questionnaire using 5 point Likert scale regarding comfort and importance of water participation for the child. A higher score indicates increased parent comfort, which is the desirable direction.

    Time frame: baseline pre-intervention; immediately after the intervention

  4. Parent perspective

    qualitative interview regarding parent perspective of the the intervention

    Time frame: one time after 8 hours of intervention have been provided to the child participant

07

Study locations

1 site
  • The Ohio State University
    Columbus, Ohio 43210, United States
08

References and documents

Individual participant data

Plan to share: No — De-identified data may be shared with other researchers.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05092321
Lead sponsor
Ohio State University
Collaborators
Franklin County Board of Developmental Disabilities
Responsible party
Erika Kemp (Assistant Professor, Clinical, Ohio State University) — Principal investigator
First posted
Oct 25, 2021
Start date
Sep 14, 2021
Primary completion
Aug 31, 2024
Completion
Aug 31, 2024
Last update
Dec 13, 2024

Study contacts

Erika Kemp
principal investigator · Ohio State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion